Nicole Votaw, PhD
Associate Director, R&D
-
Nikki Votaw is an Associate Director at Isolere Bio with her work primarily focused on addressing critical challenges in the production of advanced therapeutics, particularly for the applications of cell and gene therapy. She has dedicated several years to pioneering the development of cutting-edge protein reagents designed to optimize and enhance the manufacturing processes involved in these revolutionary therapies. The products stemming from her work have the potential to create a paradigm shift in downstream processing platforms for viral vectors in addition to profound societal impact by making curative treatments more accessible globally. Nikki is an author on multiple patents and publications stemming from both academic and industry research.
Achieving high LV yields and purity with our chromatography-free process
Associate Director of R&D for Isolere Bio, Nikki Votaw, PhD, on innovative approaches to lentiviral vector purification, achieving high yields, and purity with a chromatography-free process. View Webinar→
Breaking free from Chromatography:
Transformative AAV Purification
Director of Advanced R&D, Michael Dzuricky, Ph.D., on how IsoTag™ AAV Reagent can achieve >90% AAV capture and 60-85% elution recoveries with our baseline protocol on the first run. View Webinar→